LISA GLASS: Open Payments
NPI 1275534091 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$251 in 10 payments from 8 companies in 2025. Trend: 2023 $608 · 2024 $500 · 2025 $251
Food & beverage: $174Education: $77
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $94 |
| ABBVIE INC. | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| ViiV Healthcare Company | 1 | $24 |
| Seqirus USA Inc | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
Products named: VRAYLAR, INVEGA SUSTENNA, APRETUDE, Flucelvax, CAPLYTA, Cologuard Collection Kit, Veozah, Ozempic.
Industry payments across KY — which companies pay providers there.
